Valerie Morisset, EVP, R&D AND CSO at Eliem Therapeutics, Inc. (ELYM), sold 105,931 shares at $7.11 ($737K) on 2024-07-11, disclosed to the SEC on 2024-07-11.
Open-market sale of $737k ELYM by EVP, R&D AND CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.66 | 5,931 | $40K | 5.4% |
| 2 | $6.83 | 50,000 | $342K | 46.4% |
| 3 | $7.11 | 50,000 | $356K | 48.3% |
| Total | $6.95 avg | 105,931 | $737K | 100% |
| Filing → |
| ELYM | SELL | 2024-07-17 | $357K | — | Filing → |
| ELYM | SELL | 2024-07-16 | $948K | — | Filing → |
| ELYM | SELL | 2024-07-09 | $174K | — | Filing → |